
🇩🇰 🇩🇰 Swiss medical technology company Ypsomed’s opens new tab contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker’s next-generation experimental obesity drug CagriSema
Read More: bit.ly/Novo-CagriSema-Pens
